Paul Hofman: Paediatric Endocrinolgist talks New Zealand's high use of puberty blockers
Heather du Plessis-Allan Drive · Newstalk ZB
September 27, 20245m 9s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A view that puberty blocker use for trans youth in New Zealand needs tighter supervision.
New Zealand's use of puberty blockers is seven times higher than comparable countries.
Paediatric Endocrinologist, Paul Hofman says they shouldn't be banned as they can be effective in some cases.
He told Heather du Plessis-Allan it's not settled science.
Hofman says the evidence for puberty blocker's efficacy is not as strong as many think.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
Topics
Heather du Plessis-Allanpuberty blockerstransgender issuesteenagerspuberty